Skip to content

Insider · CIK 0001487989

Steven Nichtberger

ceopresidentofficerdirector

Files at CABA (Cabaletta Bio, Inc.). First filing Jan 21, 2026, latest Jan 21, 2026.

In brief

Steven Nichtberger files SEC Form 4 as CEO, president and director at CABA (Cabaletta Bio, Inc.). Since Jan 21, 2026, Steven Nichtberger has reported 1 open-market buy worth $101k and 0 open-market sells worth $0, the latest filed on Jan 21, 2026.

A track record needs three past buys with six months of prices behind them; Steven Nichtberger has 0, so none is measured yet.

The newest scored trade: bought $101k of CABA on Jan 21, 2026, filed Jan 21, 2026, scored 50 (moderate). In the last 12 months: 1 buy worth $101k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$101k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CABA: Cabaletta Bio, Inc.

CABAOct 9, 2026 · close 1.93

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
CABAbuy 8
Cabaletta Bio, Inc.
$101k
45,000 shares
+5%-

Transactions

Every row this insider has filed, 16 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 2, 2026CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+674,000$0.00$0674,000Mar 2, 2026
Jan 21, 2026CABA
Cabaletta Bio, Inc.
POpen-market purchase
Common Stock
+45,000$2.24$101k1,031,483Jan 21, 2026
May 19, 2025CABA
Cabaletta Bio, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-99,714$0.00$00May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+99,714$0.00$099,714May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-300,000$0.00$00May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+300,000$0.00$0300,000May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-333,500$0.00$00May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+333,500$0.00$0333,500May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-380,000$0.00$00May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+380,000$0.00$0380,000May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-411,600$0.00$00May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+411,600$0.00$0411,600May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-353,000$0.00$00May 19, 2025
May 19, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+353,000$0.00$0353,000May 19, 2025
Mar 3, 2025CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+450,000$0.00$0450,000Mar 4, 2025
Mar 1, 2024CABA
Cabaletta Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+353,000$0.00$0353,000Mar 4, 2024

Questions about Steven Nichtberger

Answered from the filings on this page, as of the latest one.

Is Steven Nichtberger buying or selling?

In the last 12 months Steven Nichtberger reported 1 open-market buy worth $101k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $101k of CABA on Jan 21, 2026. Grants, option exercises and tax withholding are not counted.

How did Steven Nichtberger's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven Nichtberger has 0.

Where does Steven Nichtberger file Form 4?

Steven Nichtberger has filed Form 4 at CABA (Cabaletta Bio, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Steven Nichtberger: insider trades and track record | InsiderTell